Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for February 2017. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Strategies Suggested to Protect Practices From Hackers
TUESDAY, Feb. 28, 2017 (HealthDay News) — Steps should be taken to protect medical practices, including small practices, from hackers, according to a report published in Medical Economics.
Physician Burnout Eroding Sense of Calling
TUESDAY, Feb. 28, 2017 (HealthDay News) — For physicians across specialties, burnout is associated with reduced odds of a sense of calling, according to a study published online Feb. 8 in the Mayo Clinic Proceedings.
Supreme Court Rules Patient Safety Data Subject to Litigation
MONDAY, Feb. 27, 2017 (HealthDay News) — The Supreme Court of Florida has reversed a District Court of Appeal decision deeming information related to patient safety unprotected from litigation discovery, according to a report published from the American Medical Association.
Depressed Psoriasis Patients at Higher Risk of Psoriatic Arthritis
MONDAY, Feb. 27, 2017 (HealthDay News) — Patients with psoriasis who also have major depressive disorder may face a much higher risk for psoriatic arthritis, according to a study published online Feb. 22 in the Journal of Investigative Dermatology.
$20 Million Awarded for Quality Payment Program Training
FRIDAY, Feb. 24, 2017 (HealthDay News) — About $20 million has been awarded to 11 organizations for the first of a five-year program to provide training and education about the Quality Payment Program for clinicians in individual or small group practices, with up to $80 million to be invested over the remaining four years, according to the U.S. Centers for Medicare & Medicaid Services (CMS).
Cyberattacks Remain Serious Threat to Health Providers
THURSDAY, Feb. 23, 2017 (HealthDay News) — Cyberattacks remain a serious threat to small providers as well as big institutions, according to a report published in Medical Economics.
Health Information Theft a Pressing Concern for U.S. Patients
WEDNESDAY, Feb. 22, 2017 (HealthDay News) — Forty-four percent of U.S. adults are worried about having their personal health care information stolen, according to findings from the Xerox eHealth Survey published Feb. 9 in HIT Consultant.
CMS Rule Set to Stabilize Small Health Insurance Markets
TUESDAY, Feb. 21, 2017 (HealthDay News) — The U.S. Centers for Medicare & Medicaid Services (CMS) has proposed a rule in relation to new reforms intended to stabilize individual and small group health insurance markets for 2018.
Internet-Delivered Exercise, Pain-Coping Skills Alleviate Knee Pain
TUESDAY, Feb. 21, 2017 (HealthDay News) — An internet-delivered physical therapist-prescribed home exercise and pain-coping skills training (PCST) intervention is beneficial for individuals with chronic knee pain, according to a study published online Feb. 21 in the Annals of Internal Medicine.
Baricitinib Associated With Significant Improvement in RA
MONDAY, Feb. 20, 2017 (HealthDay News) — For patients with rheumatoid arthritis who have had an inadequate response to methotrexate, baricitinib is associated with significant clinical improvements, compared to either placebo or adalimumab, according to a study published in the Feb. 16 issue of the New England Journal of Medicine.
Drug-Induced Lupus Seen With Adalimumab Treatment
MONDAY, Feb. 20, 2017 (HealthDay News) — In a case report published online Feb. 12 in the Journal of Clinical Pharmacy and Therapeutics, drug-induced lupus erythematosus (DILE) is described in a patient taking adalimumab for psoriasis.
Health Care Spending Expected to Grow 5.6% Annually to 2025
THURSDAY, Feb. 16, 2017 (HealthDay News) — Health care spending is expected to grow at an average annual rate of 5.6 percent from 2016 to 2025, according to a report published online Feb. 15 in Health Affairs.
FDA Approves Siliq for Plaque Psoriasis
THURSDAY, Feb. 16, 2017 (HealthDay News) — The injected drug Siliq (brodalumab) has been approved by the U.S. Food and Drug Administration to treat moderate-to-severe plaque psoriasis in adults.
Research Suggests Potential Key to Alternative Lupus Treatment
THURSDAY, Feb. 16, 2017 (HealthDay News) — In patients with systemic lupus erythematosus (SLE), mitochondrial reactive oxygen species (ROS) induce oligomerization of mitochondrial antiviral signaling (MAVS) protein and type I interferon (IFN) production, according to a study published recently in Science Signaling.
ACP Issues Guideline for Treating Acute, Subacute, Chronic LBP
TUESDAY, Feb. 14, 2017 (HealthDay News) — First-line therapy for patients with low back pain should be simple non-pharmacological remedies — from heat wraps to physical therapy, according to a new clinical practice guideline from the American College of Physicians (ACP) published online Feb. 14 in the Annals of Internal Medicine.
Review 1
Review 2
Clinical Practice Guideline
Fatigue Occurs in ~50 Percent With Chronic Plaque Psoriasis
TUESDAY, Feb. 14, 2017 (HealthDay News) — About half of patients with chronic plaque psoriasis have fatigue, according to a study published online Feb. 9 in the British Journal of Dermatology.
Full Text (subscription or payment may be required)
Ultrasound IDs Disease Activity in Rheumatoid Arthritis
TUESDAY, Feb. 14, 2017 (HealthDay News) — A 12-joint ultrasound (US) evaluation is relevant in determining disease activity in rheumatoid arthritis patients, according to a study published online Feb. 9 in the International Journal of Rheumatic Diseases.
Full Text (subscription or payment may be required)
Short-Course Tocilizumab May Up Hep B Reactivation in RA
MONDAY, Feb. 13, 2017 (HealthDay News) — For patients with rheumatoid arthritis (RA), one to three doses of tocilizumab may increase the risk of hepatitis B virus (HBV) reactivation, according to a study published online Feb. 3 in the International Journal of Rheumatic Diseases.
Full Text (subscription or payment may be required)
Yoga Linked to Low Back Pain Relief, Improvement in Function
FRIDAY, Feb. 10, 2017 (HealthDay News) — For patients experiencing low back pain, yoga may be an effective pain reliever, according to a review published online Jan. 12 in The Cochrane Library.
Full Text
Infection Risk Lower for Etanercept Vs Monoclonal Ab Rx
THURSDAY, Feb. 9, 2017 (HealthDay News) — For patients with rheumatoid arthritis, etanercept is associated with lower risk for general infections and tuberculosis compared with monoclonal antibody treatment, according to a meta-analysis published online Feb. 3 in the International Journal of Rheumatic Diseases.
Full Text (subscription or payment may be required)
Active Synovitis With Osteitis Predicts Residual Synovitis in RA
WEDNESDAY, Feb. 8, 2017 (HealthDay News) — For patients with rheumatoid arthritis (RA) who have clinical response to treatment, active synovitis with osteitis is associated with subsequent residual synovitis (R-synovitis), according to a study published online Feb. 3 in the International Journal of Rheumatic Diseases.
Full Text (subscription or payment may be required)
Treatment of Hips Beneficial in Patients With Low Back Pain
MONDAY, Feb. 6, 2017 (HealthDay News) — For individuals presenting with a primary complaint of mechanical low back pain (LBP), prescriptive treatment of the hips seems beneficial in addition to treatment of the lumbar spine, according to a study published online Jan. 27 in the Journal of Evaluation in Clinical Practice.
Full Text (subscription or payment may be required)
Zoster Ups Stroke Risk in Patients With Autoimmune Disease
FRIDAY, Feb. 3, 2017 (HealthDay News) — For patients with autoimmune diseases, the risk of stroke is increased in the few months subsequent to incident herpes zoster (HZ), according to a study published online Jan. 28 in Arthritis & Rheumatology.
Full Text (subscription or payment may be required)
NSAIDs Found to Be of Little Benefit to Patients With Back Pain
THURSDAY, Feb. 2, 2017 (HealthDay News) — Nonsteroidal anti-inflammatory drugs (NSAIDs) don’t help most patients with back pain, according to a review published online Feb. 2 in the Annals of the Rheumatic Diseases.
Gout Linked to Increased Hip Fracture Risk in Women
THURSDAY, Feb. 2, 2017 (HealthDay News) — For women, a history of gout is associated with increased risk of hip fracture, according to a study published online Jan. 28 in Arthritis & Rheumatology.
Full Text (subscription or payment may be required)
Copyright © 2017 ScoutNews, LLC. All rights reserved.
